Clipperton acted as sole financial advisor to Tilak Healthcare on its €10m growth financing led by Cap Horn and Elaia Partners, with the participation of historical investors Swen Capital Partners and iBionext Growth Fund – joined by Laboratoires Théa, the flagship of French ophthalmology – as well as Adelie, and several renowned ophthalmologists and Business Angels, including Yann Fleureau (co-founder of Cardiologs).
The funds will be used to accelerate the deployment of OdySight in France and internationally and to develop new solutions for other pathologies.
October 12th, 2023 - Tilak Healthcare, founded in 2016 within the iBionext ecosystem, is a company specializing in digital healthcare, particularly in the development of a disruptive technological platform of medical video games prescribed by healthcare professionals to support chronic disease treatments.